Supplementary Table 15 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner
Year: 2024
Type: supplementary-materials
Abstract: Hallmark pathways enriched in ID8-R cells treated with combinatory EZM8266/Olaparib compared to Olaparib alone.
Authors: Lily L. Nguyen, Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga, Tomomi M. Yamamoto, Courtney A. Bailey, Francis To, Shujian Lin, Fabian R. Villagomez, Abigail D. Jeong, Saketh R. Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Edward B. Chuong, Benjamin G. Bitler
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4404975388